mitiglinide has been researched along with liraglutide in 1 studies
| Studies (mitiglinide) | Trials (mitiglinide) | Recent Studies (post-2010) (mitiglinide) | Studies (liraglutide) | Trials (liraglutide) | Recent Studies (post-2010) (liraglutide) |
|---|---|---|---|---|---|
| 120 | 30 | 50 | 2,404 | 481 | 2,154 |
| Protein | Taxonomy | mitiglinide (IC50) | liraglutide (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0024 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, Y; Imai, J; Izumi, T; Kaneko, K; Katagiri, H; Satake, C; Sawada, S; Tanaka, M; Yamada, T; Yamamoto, J | 1 |
1 other study(ies) available for mitiglinide and liraglutide
| Article | Year |
|---|---|
Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Insulin; Insulin Antibodies; Insulin Secretion; Isoindoles; Liraglutide; Male; Postprandial Period; Treatment Outcome | 2019 |